Patent · US Expired

Phenylpyridyl compounds for inhibiting phosphodiesterase IV and methods of using same

US6153630A · kind A · utility

7Cited by
88References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 13, 1997
Grant dateNov 28, 2000
Priority date
Expiry dateNov 13, 2017

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2601/08
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Novel compounds which are effective PDE IV inhibitors are disclosed. The compounds possess improved PDE IV inhibition as compared to theophylline or rolipram as well as with improved selectivity with regard to PDE III inhibition. In certain aspects of the invention, the compounds also demonstrate PDE V inhibition. Pharmaceutical compositions containing the same and methods of treatment are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.